← Open Payments lookup

VICTORIA SPECIAN: Open Payments

NPI 1720132012 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,110 in 97 payments from 14 companies in 2025. Trend: 2023 $203 · 2024 $1,324 · 2025 $2,110

Food & beverage: $2,106Education: $4
CompanyPaymentsAmount
Alkermes, Inc.21$465
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$276
Vanda Pharmaceuticals Inc.7$275
ABBVIE INC.14$232
Otsuka America Pharmaceutical, Inc.9$190
Teva Pharmaceuticals USA, Inc.8$156
Lundbeck LLC4$110
Janssen Pharmaceuticals, Inc4$82
E.R. Squibb & Sons, L.L.C.5$78
Collegium Pharmaceutical, Inc.4$73

Products named: ARISTADA, CAPLYTA, FANAPT, REXULTI, VRAYLAR, AUSTEDO XR, LYBALVI, INVEGA SUSTENNA.

Industry payments across LA — which companies pay providers there.